ANGELA KOERPERICH: Open Payments
NPI 1629003405 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 50 payments from 13 companies in 2025. Trend: 2023 $626 · 2024 $669 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 18 | $182 |
| ABBVIE INC. | 11 | $169 |
| Lundbeck LLC | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| ACADIA Pharmaceuticals Inc | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: Azstarys, VRAYLAR, REXULTI, CAPLYTA, NUPLAZID, SPRAVATO, Jornay PM, Auvelity.
Industry payments across KS — which companies pay providers there.
